FOLLOW US:
___________

  • About
    • Steering Committee
    • Secretariat
    • Annual Reports
    • History
    • Sponsors
      • Sponsor Agreement
  • Get Involved
    • Projects
    • Conferences
  • Call to Action
    • Call to Action 2021-2022
    • Call to Action 2019-2020
    • Call to Action 2017-2019
    • Call to Action 2015-2016
    • Call to Action 2012-2014
    • Call to Action 2010-2011
  • Projects & Collaborations
    • European Testing Week
    • European Test Finder
    • INTEGRATE
    • OptTEST
    • Late Presentation for Viral Hepatitis
    • Late Presentation of HIV / Infected not yet Diagnosed
    • Indicator Condition Guided HIV Testing/HIDES
      • HIV Testing Audit Tool
      • Guidance: HIV Indicator Conditions
    • Stigma Index
    • Hepatitis B and C
    • Evidence and Practice of HIV Counselling
    • Development of the ECDC Testing Guidance for hepatitis B, hepatitis C and HIV
    • Evaluation of the 2010 ECDC HIV Testing Guidance
    • Monitoring and Evaluation of HIV testing Efforts
    • COVID-19 impact assessment on testing
  • Conferences
    • HepHIV 2023 Madrid Conference
      • Organising Committee
      • Venue
      • Conference Objectives
      • Call for Abstracts
    • HepHIV 2021 Lisbon & Virtual Conference
      • Scientific Programme
      • Presentations
        • Opening Session
        • Plenary Session 1: Special Session: Impact of COVID-19 on prevention and testing services for HIV, viral hepatitis, STIs and TB: Building back better
        • Abstract Driven Session1: The use of new technologies to increase testing coverage
        • Plenary Session 2: Combination prevention in HIV, viral hepatitis, STIs and TB
        • EU Health Project Symposium: lessons learned from the INTEGRATE Joint Action
        • Plenary Session 3: Implementing integrated testing strategies
        • Abstract Driven Session 2: Models of testing and linkage to care for PWID and PWUD
        • Plenary Session 4: Special Session: People who inject/use drugs (EMCDDA/ECDC)
        • Closing Session: Integrating disease areas and settings
        • Poster Session 1 (PO1): Innovative testing services during the COVID-19 pandemic: lessons learned
        • Poster Session 2 (PO2): Impact of COVID-19 on provision of services for people who inject/use drugs
        • Poster Session 3 (PO3): New testing technologies to increase testing coverage: HIV self-testing and home-based sampling
        • Poster Session 4 (PO4): Integrated testing programmes for hepatitis/HIV/TB/STI: health care settings
        • Poster Session 5 (PO5): Integrated testing programmes for hepatitis/HIV/TB/STI: community-based settings
        • Poster Session 6 (PO6): Models of testing and linkage to care for people who inject/use drugs
      • Side Meetings
      • Conference Objectives
      • Organising Committee
      • Newsletters
      • Auspices and Endorsers
      • Sponsors
      • For Press
    • HepHIV 2019 Bucharest Conference
      • Conference Objectives
      • Organising Committee
      • Scientific Programme
      • Presentations
        • Posters
          • Poster Category 1: Monitoring and Evaluation
          • Poster Category 2: Combination Prevention
          • Poster Category 3: Integrated Testing Strategies
          • Poster Category 4: Linkage to Care
        • Opening Session: Challenges of Timely and Integrated Testing and Care
        • Plenary Session 1: Epidemiological and Testing Policy Overview: Where are we in reaching the targets?
        • Plenary Session 2: Combination prevention
        • Plenary Session 3: Linkage to care and treatment for better outcomes: Good models and challenges
        • Plenary Session: Fast track cities initiatives: How to expand to other disease areas
        • Plenary Session: EU Health Project Symposium: Integrated Testing and Synergies
        • Plenary Special Session: The elimination of HIV and hepatitis agenda: What needs to be done?
        • Closing Session: Integration of services
        • Parallel Session 1: Monitoring and Evaluation
        • Parallel Session 2: Combination Prevention
        • Parallel Session 3: Integrated Testing Strategies
        • Parallel Session 4: Linkage to Care
      • HepHIV2019 Newsletters
      • Venue
      • Official Patronage & Endorsers
      • Sponsors
      • Scholarships
      • Photo Gallery
        • HepHIV2019 - Monday
        • HepHIV2019 - Tuesday
        • HepHIV2019 - Wednesday
    • HepHIV 2017 Malta Conference
      • HepHIV2017: Call to Action
      • Presentations
        • Opening Session
        • Plenary Session 1: Surveillance and monitoring and evaluation of testing
        • Plenary Session 2: Mixing testing strategies: Community and health care..
        • Special Session on PrEP: Influence of PrEP and new treatment paradigms ...
        • Plenary Session 3: Continuum of Care and improving linkage to care
        • Plenary Session 4: New point of care diagnostics, affordability and ..
        • Parallel Session 1: Monitoring for HIV and viral hepatitis
        • Parallel Session 2: Testing strategies in key affected populations
        • Parallel Session 3: Challenges in health care settings: Testing and linkage ...
        • Parallel Session 4: Community testing
        • Closing session
        • Poster Category 1: Monitoring for HIV and Viral Hepatitis
        • Poster Category 2: Testing Strategies in Key Affected Populations
        • Poster Category 3: Challenges in Health Care Settings and Linkage to Care
        • Poster Category 4: Community Testing
      • Scientific programme
      • Scholarships
      • Organising Committee
      • Sponsors and endorsers
      • Photo Gallery
    • HepHIV 2014 Barcelona Conference
      • HepHIV2014: Call to Action
      • Conference objective
      • Presentations
        • Opening session
        • PLE1: What´s the status of the continuum of care in HIV and viral hepatitis?
        • PLE3: Testing strategies in HV and viral hepatitis: new innovative approaches
        • PLE4: Linkage to care and economic consequences
        • PLE5: Testing and linkages to care in key populations
        • Closing session
        • PS1: Late presentation
        • PS2: Testing in health care settings
        • PS3: Key populations 1
        • PS4: Key populations 2
        • PS5: The treatment cascade
        • PS6: Alternative approaches
        • PO1/PS1: Late presentation
        • PO2/PS2: Testing in health care settings
        • PO3/PS3/PS4: Key populations
        • PO4/PS5: The treatment cascade
        • PO5/PS6: Alternative approaches
      • Scientific programme
      • Scholarships
      • Organising committee
      • Sponsors
    • Copenhagen Conference 2012
      • Copenhagen2012: Call to Action
      • Conference Objective
      • Presentations
        • Opening Session
        • Plenary - Access to earlier Testing and Care
        • Plenary - Late presenters and the undiagnosed
        • Plenary - Discussing testing strategies
        • Panel Discussion: HIV in Europe - the way forward
        • Parallel session 1
        • Parallel session 2
        • Parallel session 3
        • Parallel session 4
        • Parallel session 5
        • Parallel session 6
        • Poster category 1
        • Poster category 2
        • Poster category 3
        • Poster category 4
        • Poster category 5
        • Poster category 6
        • Poster category 7
        • Poster category 8
        • Poster category 9
        • Poster category 10
      • Scientific Programme
      • Scholarships
      • Sponsors
      • Pictures from Copenhagen 2012 Conference
    • Stockholm Conference 2009
      • Presentations
      • Reports
    • Brussels Conference 2007
  • Publications & Presentations
    • Presentations
    • Publications
  • Testing Tools
    • Integrated testing in health care settings
      • HIV Indicator Conditions
    • Integrated testing in community and low-threshold settings
    • Self-testing and self-sampling
  • News
    • Latest Publications & Outcomes
    • Newsletters
Conferencesbreadcrumb separatorHepHIV 2017 Malta Conferencebreadcrumb separatorPresentationsbreadcrumb separatorPlenary Session 1: Surveillance and monitoring and evaluation of testing

 

HIV & Viral Hepatitis: What’s Next? (VIDEO)
Alfred Sant, European Parliament

10 years of HIV in Europe – what has been achieved, what remains as challenges 
Presentation by Ton Coenen, Rutgers
Presentation by Jens Lundgren, CHIP Rigshospitalet

Test and link to care: How do we measure our success?
Valerie Delpech, PHE

Surveillance of hepatitis and hepatitis testing efforts among people who use drugs
Dagmar Hedrich, EMCDDA

 


 

COORDINATION SECRETARIAT


Rigshospitalet, University of Copenhagen
CHIP, Department of Infectious Diseases
Section 2100, Finsencentret
Blegdamsvej 9
DK-2100 Copenhagen Ø
Denmark
Tel: +45 35 45 57 57
Fax: +45 35 45 57 58
Email: eurotest.rigshospitalet@regionh.dk

ADVOCACY SECRETARIAT


Ann Isabelle von Lingen, Policy Officer
European AIDS Treatment Group (EATG)
Place Raymond Blyckaerts, 13
B-1050 Brussels, Belgium
Tel 32 2 626 96 41
M+32 491348317
Fax 32 2 644 33 07
annisabelle.vonlingen@eatg.org